Alpha-defensins as anthrax immunotherapeutics

Details Alpha-defensins as anthrax immunotherapeutics Alpha-defensins as anthrax immunotherapeutics

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2574477

The present invention relates to the use of an alpha-defensin in the manufacture of a medicament for the treatment, amelioration or prevention of a disease caused by Bacillus anthracis (B anthracis) infection. Furthermore, methods for the treatment of an B. anthracis infection as well as methods of protection against a B. anthracis infection, e.g. a vaccination are described.

Cette invention concerne l'utilisation d'une alpha-défensine dans la fabrication d'un médicament destiné à traiter, soulager ou prévenir une maladie causée par une infection au Bacillus anthracis (B. anthracis). Cette invention concerne en outre des procédés pour traiter les infections au B. anthracis, ainsi que des procédés de protection contre les infections au B. anthracis, par exemple par vaccination.

Affiliated with

Also associated with

Rating

Alpha-defensins as anthrax immunotherapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alpha-defensins as anthrax immunotherapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-defensins as anthrax immunotherapeutics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2014774